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Aim To develop specific fluorescent markers for melano-
ma tumor visualization, which would provide high selec-
tivity and reversible binding pattern, by the use of carbo-
hydrate-recognizing proteins, lectins, combined with the 
physical ability for imaging deep in the living tissues by uti-
lizing red and near infrared fluorescent properties of spe-
cific rare-earth doped nanocrystals (NC).
Methods B10F16 melanoma cells were inoculated to 
C57BL/6 mice for inducing experimental melanoma tu-
mor. Tumors were removed and analyzed by lectin-his-
tochemistry using LABA, PFA, PNA, HPA, SNA, GNA, and 
NPL lectins and stained with hematoxylin and eosin. NPL 
lectin was conjugated to fluorescent NaGdF4:Eu
3+-COOH 
nanoparticles (5 nm) via zero length cross-linking reac-
tion, and the conjugates were purified from unbound sub-
stances and then used for further visualization of histologi-
cal samples. Fluorescent microscopy was used to visualize 
NPL-NaGdF4:Eu
3+ with the fluorescent emission at 600-720 
nm range.
Results NPL lectin selectively recognized regions of undif-
ferentiated melanoblasts surrounding neoangiogenic foci 
inside melanoma tumor, PNA lectin recognized differenti-
ated melanoblasts, and LCA and WGA were bound to tu-
mor stroma regions. NPL-NaGdF4:Eu
3+ conjugated NC were 
efficiently detecting newly formed regions of melanoma 
tumor, confirmed by fluorescent microscopy in visible and 
near infrared mode. These conjugates possessed high pho-
tostability and were compatible with convenient xylene-
based mounting systems and preserved intensive fluores-
cent signal at samples storage for at least 6 months.
Conclusion NPL lectin-NaGdF4:Eu
3+ conjugated NC per-
mitted distinct identification of contours of the melanoma 
tissue on histological sections using red excitation at 590-
610 nm and near infrared emission of 700-720 nm. These 
data are of potential practical significance for development 
of glycans-conjugated nanoparticles to be used for in vivo 
visualization of melanoma tumor.
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Melanomas are considered as one of the most aggressive 
and fastest growing human tumors, and are characterized 
by high risk of metastasis and death. Since no effective 
systemic therapy exists to cure melanoma at an advanced 
stage, surgical removal of thin early-stage melanoma re-
mains the best solution for recovery. Due to its high meta-
static potential, a precise visualization of tumor contours 
during surgical incision or radio therapy is important to 
ensure and control its complete removal and save un-
affected (healthy) tissue (1,2). So far there have been no 
markers available that would ensure in vivo visualization 
of the tumor due to its intracellular accumulation of most 
molecular markers that are used to detect melanomas (3) 
and low signal-to-noise ratio of the available labels for im-
aging tissues.
Optically active inorganic nanocrystals (quantum dots, 
ie, cadmium-selene, cadmium-sulfur) have recently been 
widely used in research related to bio-medicine as effi-
cient in vivo and in vitro optical markers but also as build-
ing blocks in bio-sensors. The main reasons for this are 
their unique physical and chemical properties. As com-
pared to molecular markers (ie, green fluorescent protein, 
rhodamine), their emission is a few orders of magnitude 
stronger, more stable in time (weak blinking, no photo-
bleaching), and can be easily tuned in a wide spectral 
range simply by changing the quantum dot size. However, 
even if they are much better from the physico-chemical 
point of view, from the application point of view, at this 
moment their clinical use is still questionable mainly be-
cause of their high risk of toxicity and lack of strong coun-
ter-arguments like their optical activity in infrared spec-
tral range or multifunctionality (4). The infrared activity of 
optical probes is especially important, since the infrared 
light excitation and/or emission increases the penetra-
tion depth of light into the tissue, reducing scattering and 
autofluorescence, which all together would make them 
excellent markers for in vivo imaging.
One of the solutions, combining the advantages of both 
concepts (quantum dots and molecular markers), is to 
make nontoxic inorganic nanocrystals doped with lan-
thanide ions. These markers, because of their lack of chem-
ical toxicity, flexibility in tuning the emission, and excita-
tion properties in a wide spectral range ( ~ 400 -1600 nm) 
(4) can be designed as multifunctional probes being simul-
taneously a magnetic probe (to be used in MRI imaging), 
optical nanothermometer, or other functionalities that can 
be added to this probe due to its high surface area. In ad-
dition, these nanocrystals are characterized by extremely 
narrow emission lines (a few nm) and long emission decay 
times (up to a few ms) (4). These parameters make them 
also excellent candidates for many imaging techniques.
Recently, we have obtained sub-10 nm fluoride nanocrys-
tals doped with Eu3+ ions (5), which can be characterized 
by several emission bands, including a band at 720 nm 
depending on Eu3+ concentration (6). Since the body tis-
sues are permeable to infrared radiation outside the water 
absorbance region, the near infrared (NIR)-based imaging 
technologies are of great importance for in vivo medical 
imaging. One of the main candidates to benefit from NIR 
imaging would be melanoma, being a primary skin tumor 
with a superficial localization. This would allow precise de-
termination of tumor margins, with an aim to monitor its 
spread and control removal efficiency. Here we utilized 
NaGdF4:Eu
3+ nanocrystals, which can serve as a model of 
rare-earth NC, possessing one important feature, namely 
the ability to be easily visualized by detecting their red flu-
orescence (even by naked eye), and tested the possibility 
of NIR (or far-red) imaging with 700-720 nm fluorescence, 
which can be detected with available routine detectors.
To provide a specific but still reversible recognition of the 
melanoma cells, we screened a set of glycans-recognizing 
proteins – lectins – for their ability to bind to melanoma 
cells. Since, usually the lectin affinity binding constant with 
glycan ( ~ 10−7M) is two orders of magnitude lower than 
that of monoclonal antibodies with corresponding antigen 
( ~ 10−9M), lectin binding to tissue can be disrupted with 
the use of specific sugar inhibitors (usually non-harmful, 
sweet compounds acting at hundred nanomolar range) 
(7). Glycans posses an enormous amount of information 
and thus can serve as specific molecular markers of spe-
cific cells and tissues (8,9); glycan synthesis is usually very 
complex and thus is often disrupted in tumor cells, usu-
ally providing cells with not fully differentiated glyco-phe-
notype (8,10). Specific glycosylation changes attributable 
to melanoma tumors have been reported recently (11,12) 
and we have effectively used lectin-conjugated rare-earth-
based NC for visualization of dying cells (13,14).
Since melanoma has a wide spectrum of histological fea-
tures that mimic epithelial, hematologic, mesenchymal, 
and neural tumors (15), we hypothesized that some spe-
cific altered glycans existed in melanoma tumor and can 
serve as sensitive markers of malignant cells.
The following lectins were used to screen tumor-relat-
ed glycans: Laburnum anagyroides bark agglutinin 
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(LABA); Perca fluviatilis agglutinin (PFA); Peanut agglutinin 
(PNA); Helix pomatia agglutinin (HPA); Sambucus nigra ag-
glutinin (SNA); Galanthus nivalis agglutinin (GNA); Narcissus 
poeticus lectin (NPL); Lens culinaris agglutinin (LCA); wheat 
germ agglutinin (WGA). Many of these lectins were first dis-
covered (LABA, PFA) (16) or characterized (GNA, NPL) in our 
laboratory. Two lectins were selected as promising markers 
of undifferentiated melanoblasts and differentiated mel-
anoblasts and were further conjugated to the surface of 
NIR-emitting NC. The NC-lectin conjugates were used for 
histochemical staining and provided an intense non-pho-
tobleaching fluorescent signal in both red and NIR spectral 
part and high selectivity in visualization of melanoma tis-
sue in vitro.
MATeRiALS AnD MeTHoDS
Melanoma tumor growth and induction
The C57BL/6 mouse-derived B16F10 melanoma cell line was 
propagated in Dulbecco’s Modified Eagle Medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS) and peni-
cillin/streptomycin and was re-seeded every 3 to 5 days, so 
that a confluent layer was not formed. Cells were grown in 
culture dishes, detached from cell surface with trypsin/EDTA, 
washed in DMEM w/o serum, and centrifuged. Cell pellet re-
suspended at 40 million cells/mL and 100 µL of cell suspen-
sion (containing in total 4 million of cells) was injected sub-
cutaneously into the back region of C57BL/6 mice (17,18). 
Twelve mice (4 w/o NC and 8 injected with NC) were used 
in the experiments. C57BL/6 mice were bred at the Institute 
of Cell Biology, Lviv, Ukraine from May to December 2013 
and kept on a standard diet with drinking water available 
ad libitum. Animal hair was trimmed at the place of injection 
and tumor growth was monitored with caliper every 2 days. 
Tumor growth was monitored every two days by measuring 
its dimensions and calculating the volume. When the tumor 
dimensions exceeded 15 mm, the mouse was anesthetized 
and sacrificed. Animal studies were conducted according to 
guidelines determined by the Law of the Ministry of Health-
care of Ukraine, No. 281 from November 1, 2011 for the care 
and use of laboratory animals and were approved by Ethics 
Council of the Institute of Cell Biology.
Preparation of histological slides
Mice were sacrificed with cervical dislocation under dim-
ethyl ether anesthesia. The tumors were removed, sliced 
centromedially, fixed overnight in 4% paraformaldehyde 
in phosphate buffered saline (PBS), and embedded in par-
affin wax according to the standard protocol. For general 
morphology studies, 5 to 7-µm thick sections were stained 
with hematoxylin and eosin (HE) (19). Paraffin sections of 
melanoma tumor were deparaffinized and incubated with 
NPL-NaGdF
4:Eu
3+ NC. After this, samples where thorough-
ly washed and counterstained with 4’,6-diamidino-2-phe-
nylindole dihydrochloride (DAPI) to visualize cell nuclei (if 
needed – dried and clarified) and mounted.
Lectin-histochemistry
Deparaffinized sections were incubated for 20 min in meth-
anol containing 0.3% H2O2 to block the activity of endog-
enous peroxidase, through graded ethanol brought to PBS 
pH 7.4, rinsed in three portions of PBS (5 min each), and in-
cubated for 45 min with lectin-peroxidase conjugates (5 
μg/mL in PBS) or lectin-biotin conjugates for NPL lectin (5 
μg/mL in PBS) in a moist chamber at room temperature. In 
case of lectin-biotin conjugates, slides were washed twice 
with PBS and incubated with streptavidin-peroxidase (Vec-
tor, Burlingame, CA, USA), 1 µg/mL for 30 min at RT and 
3 × washed with PBS solution. Lectin binding sites were vi-












GNA + + ++
LABA ++ +




*Abbreviations: LABA – Laburnum anagyroides bark agglutinin; PFA – Perca fluviatilis agglutinin; PnA – Peanut agglutinin; HPA – Helix pomatia ag-
glutinin; SnA – Sambucus nigra agglutinin; GnA – Galanthus nivalis agglutinin; nPL – Narcissus poeticus lectin; LCA – Lens culinaris agglutinin; WGA 
– wheat germ agglutinin.
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sualized in PBS, containing 0.05% diaminobenzidine (Sig-
ma, St. Louis, MO, USA) and 0.015% H2O2. Thereafter, slides 
were twice washed in distilled water, and after dehydration 
mounted in balsam. For semiquantitative evaluation of lec-
tin binding, two investigators performed the analysis inde-
pendently, blinded to lectin type. Binding intensity was eval-
uated using a semiquantitative scale as follows: +++ very 
strong, ++ strong, + weak positive, and - negative labeling 
(not shown) (Table 1).
Conjugation of lectin with nC
The hydrophobic NaGdF4:Eu
3+ nanocrystals were obtained 
by modified co-thermolysis method described elsewhere 
(5). Their functionalization to hydrophilic NaGdF4:Eu
3+-
COOH form was obtained according to our variant of li-
gand exchange method, which is patent pending. We add-
ed to NC solution in toluene another solution containing 
hydrophilic ligand and mixed them for some time under 
inert conditions. In particular, we substituted trioctylphos-
phine oxide (TOPO) with meso-2,3-dimercaptosuccinic 
acid (DMSA), which resulted in water dispersible NCs with 
COOH groups on their surface.
NaGdF4:Eu
3+ - COOH were sonicated and filtered through 
0.22 µm-pore filter and transferred to MES 0.1M pH 4.5 buf-
fer. Lectin to be used for conjugation was dissolved in MES, 
0.1M, pH 4.5 at 10 mg/mL. 2 mg of protein was added to 
every 1 mL of NC suspension (containing 10 mg of NC). 
EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hy-
drochloride) was added to the reaction medium to obtain 
final 2% concentration. Suspension was reacted for 2 h at 
RT under constant mixing. The obtained suspension was 
dialyzed against PBS 3 times. For storage purposes, BSA 
(1% final concentration) and sodium azide (0.05% final 
concentration) were added to NC suspension. Purification 
of NPL- NaGdF4:Eu
3+ was conducted in 1% agarose gel with 
loading of either 20 µL of lectin-NC suspension or 20 µg of 
lectin per well. Agarose gel electrophoresis was performed 
according to routine laboratory procedures. Agarose was 
stained with Coomasie G-250 (Carl Roth, Karlsruhe, Germa-
ny) and scanned.
Fluorescent microscopy
Fluorescent microscopy was performed with fixed slides un-
der a Carl Zeiss AxioImager A1 DIC/fluorescent microscope 
(Oberkochen, Germany) using 0.4NA 10 × , 0.75 NA 40 × air, 
and 1.3 NA 100 × oil immersion objectives. Fluorescent imag-
es were taken by a Zeiss AxioCam MRmIII cooled digital CCD 
camera under constant exposure. Fluorescence of NC was 
evaluated at red channel (610 nm emission was obtained 
at 532 nm excitation) and at similar conditions the emission 
at NIR channel (700 nm) was detected. In parallel, the near-
est tumor slices were stained with HE and imaged for com-
parison. HE images were made at the same microscope set 
up using additional Canon (Tokyo, Japan) CCD RGB camera 
with constant focus and exposure settings; Zeiss AxioVision 
and ImageJ software (National Institutes of Health, Bethes-
da, MD, USA) were used for image analysis. TEM microsco-
py and spectroscopy analysis were performed as described 
previously (6). Statistical analysis was performed in Microsoft 
Excel, using t test and P < 0.05 was considered significant.
ReSULTS
Growth of the melanoma tumor
On average, melanoma tumors reached 15 mm in diame-
ter within 17 days (range, 14-24 days). Mean weight (±stan-
dard error of the mean) of the tumor was 860 ± 160 mg, 
and it caused involvement of regional lymph node and 
was classified as level-III, T4 and level-IV, T4 (1). In case of 
no treatment, B16F10 melanoma evolved to its metastatic 
stage and killed mice within weeks after inoculation, as re-
ported previously (20).
FiGURe 1. Melanoma growth was accompanied by progres-
sion of undifferentiated melanoblasts (umb) surrounding 
neoangiogenic vessels (v). Subsequently umb differentiated 
to melanoblasts (dmb) that produce melanin (m) as well as 
to melanocytes (mc) that form tumor stroma. (A) an entire 
(intact) tumor 8 days after inoculation, a prevalence of undif-
ferentiated cells can be clearly seen. (B,C) a differentiated 
melanin-rich tissue was formed (micrographs on different 
magnifications were taken 15 days after cell inoculation).
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Melanoma tumor at the beginning of its growth was 
characterized as a solid tumor with high angiogenesis 
and huge accumulation of undifferentiated melano-
blasts (umb) around newly formed vessels, which does 
not produce much melanin (granules of melanin were 
rare on histological sections but the tumor itself was of 
black color) (Figure 1A). Further growth of the tumor was 
characterized by prominent angiogenesis with vessels 
surrounded by undifferentiated melanoblasts, and differ-
entiation of melanoblasts to both melanocytes and their 
contribution to formation of tumor stroma (judged by 
melanin granules) cells was noticed (Figure 1). A subse-
quent growth caused the occurrence of internal necrosis 
areas surrounded with prominent lymphocyte infiltrates 
in the main tumor and formation of metastasis, which 
caused death (not shown). Based on the observed data, 
we subdivided melanoma tissue into a few regions ac-
cording to Serov et al (21): undifferentiated melanoblasts, 
usually forming islets round vessels; differentiated mel-
anoblasts producing melanin; and regions of tumor stro-
ma (connective tissue).
Glycomarkers of different melanoma regions
A set of lectins, binding specific tumor-related or cell 
death-related glycans were used to screen for an ability to 
bind distinct melanoma regions. Our goal was to find the 
lectin that would selectively bind to big multinucleated 
(with multiple nuclei) metabolically active undifferentiat-
ed melanoblasts by forming surrounding coating around 
neoangiogenic vessel, since they initiate the process of 
melanoma progression and possess the primarily danger. 
The lectins LABA (16,22) and PFA (23) used in the current 
work were discovered and GNA and NPL were character-
ized in our laboratory and were shown to possess an af-
finity toward altered, tumor-related glycoepitops, while 
NPL lectin was shown to be a promising marker of dying 
cells (24). The screened lectin panel showed preferential 
binding with distinct parts of melanoma tumors, allowing 
discrimination of tumor part based on their glycan com-
position (Figure 2, Table 1). PFA lectin demonstrated high 
specificity toward endothelium of neoangiogenic vessels. 
PNA lectin (specific to desialylated glycoepitops, namely 
FiGURe 2. Lectin-histochemical analysis of different tumor regions. Lectins used for staining are indicated at top left. Lectin signal is 
in brown color. Hematoxylin and eosin staining is shown for the same tumor region as for nPL (subsequent slices were used). objec-
tive ×10.
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to TF-antigen, is widely used in cancer research and di-
agnostic histopathology) (25) showed preferential bind-
ing with differentiated melanoblast and melanocytes in 
tumor stroma. GNA and especially NPL lectins (both spe-
cific to oligomannose-rich glycans) showed preferential 
binding with regions of undifferentiated melanoblasts, 
which was especially noteworthy for NPL lectin. Thus, we 
selected NPL for further experiments of fluorescent visu-
alization of malignant melanoma tissue.
Creation of lectin conjugates with fluorescent rare-
earth nanoparticles
Fluorescent NaGdF4:Eu
3+ NC were chosen for this study 
according to their excitation levels with conventionally 
available excitation light source and their ability to pro-
duce red and near-IR fluorescence, which we detected 
with the use of standard CCD cameras or other equip-
ment. This matrix can be easily modified to emit light in 
NIR-IR range by simple exchange of lanthanide ions (ie, to 
Er or Tm) and can be potentially used for visualization of 
deep layers of tissues in vivo. NaGdF4:Eu
3+ NC had hexago-
nal structure with mean diameter of 5 nm, as well as high 
photostability, and provided high fluorescence intensity 
in the red region (590 nm with full width at half maxi-
mum [FWHM] 12 nm and 615 nm with FWHM of 10 nm) 
and NIR region (700 nm with FWHM of 12 nm) (Figure 3, A 
and B). The surface of NC was modified according to our 
patent-pending method to make NCs water dispersible 
and to contain free carboxylic groups, which were further 
coupled to the targeted protein (NPL) via zero-length 
crosslinking reaction, using 1-ethyl-3-(3-dimethylamino-
propyl)carbodiimide hydrochloride (Figure 3D). Unbound 
chemicals and uncoupled proteins were purified by dialy-
sis and control of unbound proteins was done using 1% 
agarose gel electrophoresis. Free NPL protein was free-
ly migrating in the agarose gel under the electric field, 
while NPL-NaGdF4:Eu
3+ NC conjugates remained at their 
loading place and no traces of unbound proteins were 
detected (Figure 3E). NPL- NaGdF4:Eu
3+ NC conjugates, 
which we created, were used for imaging of paraffin sec-
tions of melanoma tumors.
FiGURe 3. Properties of nPL- naGdF4:eu
3+ nanocrystal (nC). (A) nC fluorescence is induced by 395 nm wavelength; (B) HRTeM image 
of naGdF4:eu
3+ crystals revealed the diameter of 5 nm; (C) excitation and emission spectra of naGdF4:eu
3+ nC; (D) scheme of nC con-
jugation with protein via zero-length cross linking reaction. (E) agarose gel electrophoresis of nPL protein and its conjugates with 
nC after extensive dialysis. no unbound protein was detected.
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imaging of melanoma tissue using fluorescent nPL-
naGdF4:eu
3+ nanocrystals
Both water- and organic solvent-based mounting media 
were tested while mounting histological slides stained with 
conjugated NaGdF4:Eu
3+ NC, and Canada-balsam based 
media showed excellent results for preserving the slides; 
NaGdF4:Eu
3+ NC were compatible with xylene-containing 
mounting systems. NPL-NaGdF4:Eu
3+ provided excellent 
signal-to-noise ratio when staining melanoma tumor and 
discriminating regions of undifferentiated melanoblasts 
and neoangiogenesis (Figure 4B) as compared to conven-
tional HE staining (Figure 4A). Even after dozens of minutes 
of intense examination, the signal was not fading out. A 
repeated test for intensity showed that even after 1 and 
6 months fluorescent signal did not exhibit any degrada-
tion. NPL-NaGdF4:Eu
3+ NC provided strong signal in both 
red (Figure 4C) and NIR region (Figure 4D) and could be 
easily combined with DAPI counterstaining (Figure 4 E,F) 
for cell nuclei visualization.
DiSCUSSion
This is the first study demonstrating the effectiveness of 
using rare-earth based NC for visualization of melanoma 
tumors in the near-IR spectral range. Selection of appropri-
ate NC with strong emission in the IR is expected to allow 
future effective tracing of superficial tumors like melano-
ma with the aim to localize all tumor tissues and effectively 
remove it during surgery, while not destroying normal tis-
sue. Small size of NC, their low toxicity (our currently un-
published data) and availability of specific lectin-based gly-
FiGURe 4. Visualization of undifferentiating neovascularized melanoma regions with nPL-naGdF4:eu3+ nanocrystals (nC). Melanoma 
slice stained with hematoxylin and eosin (A) is compared with sequential slice stained with nC conjugates, using near-infrared (niR) 
fluorescence detection mode. (B) nC provided two fluorescence peaks and were imaged using ex. 546/12nm, em. 610/60nm (a typi-
cal red fluorescent signal) with exposure of 500 ms (C); the same samples emitting at 690/50 nm (a niR fluorescence, imaging using 
Carl Zeiss filter set 50) with exposure of 1100 ms were imaged at (D); cell nuclei of the sample in (C) and (D) were counterstained 
with 4’,6-diamidino-2-phenylindole dihydrochloride (E); (F) merged images D and e.
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can markers providing reversible binding pattern should 
allow possible injections of NC-based labels and their sub-
sequent removal from the organism.
It should be mentioned that both NPL and GNA lectins, 
which selectively label undifferentiated melanoblasts, 
are both specific to oligomannose glycans, namely oli-
gomanose 5-9 glycans found as immature components 
of N-glycan biosynthesis pathways in the endoplasmic 
reticulum (ER) (26). Both have been previously reported 
as promising markers of apoptotic cells (24,27) and it has 
been shown that ER membranes contribute to compen-
sation of cell surface membrane loss at apoptotic bleb-
bing (24). Since the observed melanoblasts were typical 
undifferentiated cells with high metabolism (note mul-
tiple nucleoli seen in Figure 4 E,F), we can assume that 
they expose immature ER-related glycans on their surface 
due to incomplete N-glycan biosynthesis. A new group 
of mannoside-based compounds that blocks interactions 
involving oligomannose glycans was described recently 
(7,28). These compounds are in high demand as they can 
block the binding of E coli oligomanno-specific adhesine 
with host cell surface and are foreseen to be novel types 
of drugs for preventing bacterial re-infection cycles and 
host cell colonization during uropahtogenic infections 
and Crohn disease, both contributed to by E coli host 
cell invasion (29,30). The availability of compounds that 
would reversibly detach the NPL-NaGdF4:Eu
3+ NC from 
their bound target is especially important for effective 
removal of NC from the organism after diagnostic pro-
cedure.
It is worth mentioning that although NIR irradiation of 710 
nm produced by the studied NC cannot be detected by 
naked eye, it can be easily detected with conventional CCD 
and CMOS cameras (as well as FL4 detectors in most flow 
cytometers), whereas NC fluorescence in the red region 
(590 and 610 nm) can be easily observed by human eye 
under fluorescent microscope. Thus, the current finding 
can allow the creation of NIR NC targeted to label specific 
tumor regions based on altered glycoprofile. Imaging of 
such crystals after intravenous injection will allow a precise 
determination of tumor margins before its removal, while 
available synthetic glycan compound should allow mak-
ing the binding reversible and removing NC from the or-
ganism after imaging. In conclusion, we showed that spe-
cific lectins can be effectively used to discriminate regions 
of melanoma and that their conjugates with rare-earth 
fluorescent nanocrystals provided efficient visualization of 
malignant melanoma tumors.
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